Literature DB >> 15173583

Protection against lethal influenza virus challenge by RNA interference in vivo.

Stephen Mark Tompkins1, Chia-Yun Lo, Terrence M Tumpey, Suzanne L Epstein.   

Abstract

Influenza virus infection is responsible for hundreds of thousands of deaths annually. Current vaccination strategies and antiviral drugs provide limited protection; therefore, new strategies are needed. RNA interference is an effective means of suppressing virus replication in vitro. Here we demonstrate that treatment with small interfering RNAs (siRNAs) specific for highly conserved regions of the nucleoprotein or acidic polymerase inhibits influenza A virus replication in vivo. Delivery of these siRNAs significantly reduced lung virus titers in infected mice and protected animals from lethal challenge. This protection was specific and not mediated by an antiviral IFN response. Moreover, influenza-specific siRNA treatment was broadly effective and protected animals against lethal challenge with highly pathogenic avian influenza A viruses of the H5 and H7 subtypes. These results indicate that RNA interference is promising for control of influenza virus infection, as well as other viral infections.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15173583      PMCID: PMC423255          DOI: 10.1073/pnas.0402630101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

Review 1.  RNA interference.

Authors:  Gregory J Hannon
Journal:  Nature       Date:  2002-07-11       Impact factor: 49.962

2.  Short interfering RNA confers intracellular antiviral immunity in human cells.

Authors:  Leonid Gitlin; Sveta Karelsky; Raul Andino
Journal:  Nature       Date:  2002-06-26       Impact factor: 49.962

3.  Efficient delivery of siRNA for inhibition of gene expression in postnatal mice.

Authors:  David L Lewis; James E Hagstrom; Aaron G Loomis; Jon A Wolff; Hans Herweijer
Journal:  Nat Genet       Date:  2002-07-29       Impact factor: 38.330

4.  Heterosubtypic immunity to influenza A virus in mice lacking IgA, all Ig, NKT cells, or gamma delta T cells.

Authors:  K A Benton; J A Misplon; C Y Lo; R R Brutkiewicz; S A Prasad; S L Epstein
Journal:  J Immunol       Date:  2001-06-15       Impact factor: 5.422

5.  Molecular correlates of influenza A H5N1 virus pathogenesis in mice.

Authors:  J M Katz; X Lu; T M Tumpey; C B Smith; M W Shaw; K Subbarao
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

6.  Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group.

Authors:  K G Nicholson; F Y Aoki; A D Osterhaus; S Trottier; O Carewicz; C H Mercier; A Rode; N Kinnersley; P Ward
Journal:  Lancet       Date:  2000-05-27       Impact factor: 79.321

7.  Lethal H5N1 influenza viruses escape host anti-viral cytokine responses.

Authors:  Sang Heui Seo; Erich Hoffmann; Robert G Webster
Journal:  Nat Med       Date:  2002-08-26       Impact factor: 53.440

8.  RNA interference in adult mice.

Authors:  Anton P McCaffrey; Leonard Meuse; Thu-Thao T Pham; Douglas S Conklin; Gregory J Hannon; Mark A Kay
Journal:  Nature       Date:  2002-07-04       Impact factor: 49.962

9.  DNA vaccine expressing conserved influenza virus proteins protective against H5N1 challenge infection in mice.

Authors:  Suzanne L Epstein; Terrence M Tumpey; Julia A Misplon; Chia-Yun Lo; Lynn A Cooper; Kanta Subbarao; Mary Renshaw; Suryaprakash Sambhara; Jacqueline M Katz
Journal:  Emerg Infect Dis       Date:  2002-08       Impact factor: 6.883

10.  Modulation of HIV-1 replication by RNA interference.

Authors:  Jean-Marc Jacque; Karine Triques; Mario Stevenson
Journal:  Nature       Date:  2002-06-26       Impact factor: 69.504

View more
  142 in total

1.  Double-stranded RNA induces sequence-specific antiviral silencing in addition to nonspecific immunity in a marine shrimp: convergence of RNA interference and innate immunity in the invertebrate antiviral response?

Authors:  Javier Robalino; Thomas Bartlett; Eleanor Shepard; Sarah Prior; Guillermo Jaramillo; Edward Scura; Robert W Chapman; Paul S Gross; Craig L Browdy; Gregory W Warr
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

Review 2.  Development of resistance to RNAi in mammalian cells.

Authors:  Zhi-Ming Zheng; Shuang Tang; Mingfang Tao
Journal:  Ann N Y Acad Sci       Date:  2005-11       Impact factor: 5.691

Review 3.  RNA interference and antiviral therapy.

Authors:  Yan Ma; Chu-Yan Chan; Ming-Liang He
Journal:  World J Gastroenterol       Date:  2007-10-21       Impact factor: 5.742

Review 4.  Therapeutic regulation of gene expression in the inner ear using RNA interference.

Authors:  Yukihide Maeda; Abraham M Sheffield; Richard J H Smith
Journal:  Adv Otorhinolaryngol       Date:  2009-06-02

Review 5.  Pandemic and seasonal influenza: therapeutic challenges.

Authors:  Matthew J Memoli; David M Morens; Jeffery K Taubenberger
Journal:  Drug Discov Today       Date:  2008-05-15       Impact factor: 7.851

6.  Application of siRNA against SARS in the rhesus macaque model.

Authors:  Qingquan Tang; Baojian Li; Martin Woodle; Patrick Y Lu
Journal:  Methods Mol Biol       Date:  2008

Review 7.  Lipidic systems for in vivo siRNA delivery.

Authors:  Sherry Y Wu; Nigel A J McMillan
Journal:  AAPS J       Date:  2009-09-09       Impact factor: 4.009

Review 8.  Strategies for targeted nonviral delivery of siRNAs in vivo.

Authors:  Sang-Soo Kim; Himanshu Garg; Anjali Joshi; N Manjunath
Journal:  Trends Mol Med       Date:  2009-10-19       Impact factor: 11.951

9.  RNA interference-mediated virus clearance from cells both acutely and chronically infected with the prototypic arenavirus lymphocytic choriomeningitis virus.

Authors:  Ana B Sánchez; Mar Perez; Tatjana Cornu; Juan Carlos de la Torre
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

10.  Delivery of RNAi reagents in murine models of obesity and diabetes.

Authors:  Denise M Wilcox; Ruojing Yang; Sherry J Morgan; Phong T Nguyen; Martin J Voorbach; Paul M Jung; Deanna L Haasch; Emily Lin; Eugene N Bush; Terry J Opgenorth; Peer B Jacobson; Christine A Collins; Cristina M Rondinone; Terry Surowy; Katherine T Landschulz
Journal:  J RNAi Gene Silencing       Date:  2006-11-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.